Table 1. The clinical and demographic characteristics of HCC cases and clinical controls.
| HCC patients |
Healthy Controls |
||||
|---|---|---|---|---|---|
| N | % | N | % | ||
| Age | |||||
| 50-54 | 2 | 10.53 | 3 | 15.79 | |
| 55-59 | 5 | 26.32 | 5 | 26.32 | |
| 60-64 | 4 | 21.05 | 4 | 21.05 | |
| 65-69 | 5 | 26.32 | 3 | 15.79 | |
| 70-74 | 3 | 15.79 | 3 | 15.79 | |
| 75-79 | 0 | 0 | 1 | 5.26 | |
| Gender | |||||
| Male | 17 | 89.47 | 17 | 89.47 | |
| Female | 2 | 10.53 | 2 | 10.53 | |
| Tumor Stage | |||||
| I | 10 | 52.63 | 0 | 0 | |
| II | 0 | 0 | 0 | 0 | |
| III | 8 | 42.05 | 0 | 0 | |
| ⅢA | 1 | 5.26 | 0 | 0 | |
| ⅢB | 1 | 5.26 | 0 | 0 | |
| ⅢC | 6 | 31.58 | 0 | 0 | |
| IV | 1 | 5.26 | 0 | 0 | |
| Clinical settings combined | |||||
| HBsAg (+) | 17 | 89.47 | 0 | 0 | |
| Anti-HCV (+) | 0 | 0 | 0 | 0 | |
| Liver cirrhosis | 18 | 94.74 | 0 | 0 | |